APRICUS BIOSCIENCES, INC. Uncategorized Contracts & Agreements
44 Contracts & Agreements
- Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 6, 2024)
- Placement Agent Agreement, dated January 26, 2024 (Filed With SEC on January 30, 2024)
- Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 10, 2023)
- Open Market Sale AgreementSM, dated as of May 12, 2022, by and between Seelos Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 12, 2022)
- Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 4, 2022)
- Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 17, 2020)
- Form of Leak-Out Agreement (Filed With SEC on August 27, 2019)
- Seelos Therapeutics, Inc. 2019 Inducement Plan (Filed With SEC on August 14, 2019)
- Form of Fourth Amendment Agreement (Filed With SEC on March 8, 2019)
- Form of Third Amendment Agreement (Filed With SEC on January 16, 2019)
- Form of Second Amendment Agreement (Filed With SEC on January 4, 2019)
- Form of Amendment Agreement (Filed With SEC on November 16, 2018)
- Form of Investor Warrants (Filed With SEC on November 16, 2018)
- Form of Lock-Up Agreement (Filed With SEC on October 17, 2018)
- Form of Investor Warrants (Filed With SEC on October 17, 2018)
- Indemnity Agreement, dated July 8, 2016, by and between Seelos Therapeutics, Inc. and Raj Mehra, Ph.D (Filed With SEC on August 31, 2018)
- Engagement Letter, between Apricus Biosciences, Inc. and Canaccord Genuity LLC, dated as of March 22, 2018 (Filed With SEC on August 31, 2018)
- Form of CVR Agreement (Filed With SEC on July 30, 2018)
- Support Agreement, dated July 30, 2018, by and between Apricus Biosciences, Inc., Seelos Therapeutics, Inc. and Raj Mehra (Filed With SEC on July 30, 2018)
- Form of Support Agreement, by and between Apricus Biosciences, Inc., Seelos Therapeutics, Inc. and certain stockholders of Apricus Biosciences, Inc (Filed With SEC on July 30, 2018)
- Engagement Agreement, dated as of March 27, 2018, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on March 29, 2018)
- Engagement Letter between Apricus Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of September 10, 2017 (Filed With SEC on September 11, 2017)
- [To be separately provided to the Investor] (Filed With SEC on January 13, 2016)
- [To be separately provided to the Investors] (Filed With SEC on January 13, 2016)
- [To be separately provided to the Investors] (Filed With SEC on January 13, 2016)
- AMENDMENT TO WARRANTS (Filed With SEC on January 13, 2016)
- [To be separately provided to the Investor] (Filed With SEC on February 12, 2015)
- [To be separately provided to the Investors] (Filed With SEC on February 12, 2015)
- APRICUS BIOSCIENCES, INC. CONTROLLED EQUITY OFFERING AMENDMENT NO. 1 TO CONTROLLED EQUITY OFFERING AGREEMENT (Filed With SEC on May 10, 2013)
- ASSETPURCHASE AGREEMENT (Filed With SEC on April 1, 2013)
- APRICUS BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENTAGREEMENT (Filed With SEC on March 20, 2013)
- APRICUS BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENTAGREEMENT (Filed With SEC on March 20, 2013)
- AGREEMENT (Filed With SEC on March 18, 2013)
- AMENDMENT (Filed With SEC on March 18, 2013)
- CONTROLLED EQUITY OFFERING AGREEMENT (Filed With SEC on December 30, 2011)
- Custodian (Filed With SEC on March 24, 2011)
- AMENDMENTNO. 2 TO RIGHTS AGREEMENT (Filed With SEC on December 10, 2009)
- TerminationAgreement (Filed With SEC on August 10, 2009)
- FIRSTAMENDMENT TO ASSETPURCHASE AGREEMENT (Filed With SEC on April 17, 2009)
- LICENSEAGREEMENT (Filed With SEC on February 5, 2009)
